Ray Zemlin, a senior partner in Goodwin Procter’s Technology Companies & Life Sciences Group, focuses primarily on securities law, mergers and acquisitions, and corporate finance matters for medical device and other companies. He has more than 30 years’ experience representing issuers and underwriters in public and private offerings of equity and debt securities, as well as counseling numerous public companies on securities law, governance and other issues. In addition, he has represented purchasers or sellers in hundreds of merger and acquisition transactions, including representing ZOLL Medical in its $2.2 billion sale to Asahi Kasei, and advised managements and boards of directors on a host of corporate governance and related matters.

Mr. Zemlin is a recognized leader in the medical device community and has served on the board of directors of MassMEDIC, the country’s largest medical device industry council.